Tanshinone IIA suppresses endoplasmic reticulum stress-induced apoptosis of high glucose-conditioned vascular endothelial cells by regulating microRNA-133/RAC-1 pathway
Main Article Content
Keywords
tanshinone IIA, microRNA-133, RAC-1, endoplasmic reticulum stress, apoptosis, human umbilical vein endothelial cells
Abstract
Cellular stress caused by abnormal accumulation of unfolded or misfolded proteins in the endoplasmic reticulum (ER) is becoming a possible driver of cardiovascular diseases. The primary aim of our study was to explore Tanshinone IIA (Tan IIA)-induced protection against ER-induced apoptosis of human umbilical vein endothelial cells (HUVECs). HUVECs were treated with high glucose (HG), administrated with Tan IIA (2.5, 5, and 10 μM), and transfected with microRNA-133 (miR-133) mimic or inhibitor. Then cell viability was evaluated by MTT assay, the release of lactate dehydrogenase (LDH) was measured by detection kit, and ER stress was analyzed by Western blot measurement of ER stress-related indicators. Cell apoptosis was observed through flow cytometry and Western blot analysis of apoptosis-related markers. miR-133 and RAC-1 expressions in HUVECs were assessed. For HUVECs, HG inhibited cellular survival, promoted the release of LDH, apoptosis and ER stress, down-regulated miR-133, and up-regulated RAC-1. We demonstrated that Tan IIA reverted the damage of HG to HUVECs in a concentration-dependent manner. miR-133 could negatively regulate RAC-1 expression, and Tan IIA inhibited RAC-1 expression by elevating miR-133, thereby reducing the damage of HG to HUVECs. Tan IIA regulates miR-133–RAC-1 axis to reduce the apoptosis caused by ER stress in HG-induced HUVECs, which could provide new insights for treating cardiovascular diseases.
References
Chan, P., Chen, Y.C., Lin, L.J., Cheng, T.H., Anzai, K., Chen, Y.H., Liu, Z.M., Lin, J.G. and Hong, H.J., 2012. Tanshinone IIA attenuates H(2)O(2)-induced injury in human umbilical vein endothelial cells. American Journal of Chinese Medicine 40: 1307–1319. 10.1142/S0192415X12500966
Chelvanambi, S., Gupta, S.K., Chen, X., Ellis, B.W., Maier, B.F., Colbert, T.M., Kuriakose, J., Zorlutuna, P., Jolicoeur, P., Obukhov, A.G. and Clauss, M., 2019. HIV-Nef protein transfer to endothelial cells requires Rac1 activation and leads to endothelial dysfunction implications for statin treatment in HIV patients. Circulation Research 125: 805–820. 10.1161/CIRCRESAHA.119.315082
Chen, J., Bi, Y., Chen, L., Zhang, Q. and Xu, L., 2018. Tanshinone IIA exerts neuroprotective effects on hippocampus-dependent cognitive impairments in diabetic rats by attenuating ER stress-induced apoptosis. Biomedicine & Pharmacotherapy 104: 530–536. 10.1016/j.biopha.2018.05.040
Cheng, Q., Zhao, Y. and Li, J., 2017. Sodium tanshinone IIA sulfonate suppresses heat stress-induced endothelial cell apoptosis by promoting NO production through upregulating the PI3K/AKT/eNOS pathway. Molecular Medicine Reports 16: 1612–1618. 10.3892/mmr.2017.6760
Deng, H., Yu, B. and Li, Y., 2021. Tanshinone IIA alleviates acute ethanol-induced myocardial apoptosis mainly through inhibiting the expression of PDCD4 and activating the PI3K/Akt pathway. Phytotherapy Research 35: 4309–4323. 10.1002/ptr.7102
Dong, D.L., Chen, C., Huo, R., Wang, N., Li, Z., Tu, Y.J., Hu, J.T., Chu, X., Huang, W. and Yang, B.F., 2010. Reciprocal repression between microRNA-133 and calcineurin regulates cardiac hypertrophy: a novel mechanism for progressive cardiac hypertrophy. Hypertension 55: 946–952. 10.1161/HYPERTENSIONAHA.109.139519
Dong, Y., Fernandes, C., Liu, Y., Wu, Y., Wu, H., Brophy, M.L., Deng, L., Song, K., Wen, A., Wong, S., Yan, D., Towner, R. and Chen, H., 2017. Role of endoplasmic reticulum stress signalling in diabetic endothelial dysfunction and atherosclerosis. Diabetes and Vascular Disease Research 14: 14–23. 10.1177/1479164116666762
Feng, J., Li, S. and Chen, H., 2016. Tanshinone IIA ameliorates apoptosis of cardiomyocytes induced by endoplasmic reticulum stress. Experimental Biology and Medicine (Maywood) 241: 2042–2048. 10.1177/1535370216660634
Feng, J., Liu, L., Yao, F., Zhou, D., He, Y. and Wang, J., 2021. The protective effect of tanshinone IIa on endothelial cells: a generalist among clinical therapeutics. Expert Review of Clinical Pharmacology 14: 239–248. 10.1080/17512433.2021.1878877
Fresta, C.G., Caruso, G., Fidilio, A., Platania, C.B.M., Musso, N., Caraci, F., Drago, F. and Bucolo, C., 2020. Dihydrotanshinone, a natural diterpenoid, preserves blood-retinal barrier integrity via P2X7 receptor. International Journal of Molecular Sciences 21(23): 9305. 10.3390/ijms21239305
Guo, S., Yao, Q., Ke, Z., Chen, H., Wu, J. and Liu, C., 2015. Resveratrol attenuates high glucose-induced oxidative stress and cardiomyocyte apoptosis through AMPK. Molecular and Cellular Endocrinology 412: 85–94. 10.1016/j.mce.2015.05.034
He, L., Liu, Y.Y., Wang, K., Li, C., Zhang, W., Li, Z.Z., Huang, X.Z. and Xiong, Y., 2021. Tanshinone IIA protects human coronary artery endothelial cells from ferroptosis by activating the NRF2 pathway. Biochemical and Biophysical Research Communications 575: 1–7. 10.1016/j.bbrc.2021.08.067
He, Y., Ruganzu, J.B., Lin, C., Ding, B., Zheng, Q., Wu, X., Ma, R., Liu, Q., Wang, Y., Jin, H., Qian, Y., Peng, X., Ji, S., Zhang, L., Yang, W. and Lei, X., 2020. Tanshinone IIA ameliorates cognitive deficits by inhibiting endoplasmic reticulum stress-induced apoptosis in APP/PS1 transgenic mice. Neurochemistry International 133: 104610. 10.1016/j.neuint.2019.104610
Hetz, C., 2012. The unfolded protein response: controlling cell fate decisions under ER stress and beyond. Nature Reviews Molecular Cell Biology 13: 89–102. 10.1038/nrm3270
Hu, H., Tian, M., Ding, C. and Yu, S., 2018. The C/EBP homologous protein (CHOP) transcription factor functions in endoplasmic reticulum stress-induced apoptosis and microbial infection. Frontiers in Immunology 9: 3083. 10.3389/fimmu.2018.03083
Koditz, J., Nesper, J., Wottawa, M., Stiehl, D.P., Camenisch, G., Franke, C., Myllyharju, J., Wenger, R.H. and Katschinski, D.M., 2007. Oxygen-dependent ATF-4 stability is mediated by the PHD3 oxygen sensor. Blood 110: 3610–3617. 10.1182/blood-2007-06-094441
Li, Q., Lin, Y., Wang, S., Zhang, L. and Guo, L., 2017. GLP-1 inhibits high-glucose-induced oxidative injury of vascular endothelial cells. Science Reporter 7: 8008. 10.1038/s41598-017-06712-z
Li, Q., Shen, L., Wang, Z., Jiang, H.P. and Liu, L.X., 2016. Tanshinone IIA protects against myocardial ischemia reperfusion injury by activating the PI3K/Akt/mTOR signaling pathway. Biomedicine & Pharmacotherapy 84: 106–114. 10.1016/j.biopha.2016.09.014
Li, J., Zhu, H., Shen, E., Wan, L., Arnold, J.M. and Peng, T., 2010. Deficiency of rac1 blocks NADPH oxidase activation, inhibits endoplasmic reticulum stress, and reduces myocardial remodeling in a mouse model of type 1 diabetes. Diabetes 59: 2033–2042. 10.2337/db09-1800
Li, Y., Fu, Y., Sun, J., Shen, J., Liu, F., and Ning, B., 2022. Tanshinone IIA alleviates NLRP3 inflammasome-mediated pyroptosis in Mycobacterium tuberculosis-(H37Ra-) infected macrophages by inhibiting endoplasmic reticulum stress. Journal of Ethnopharmacology 282: 114595. 10.1016/j.jep.2021.114595
Lu, W., Lin, J., Zheng, D., Hong, C., Ke, L., Wu, X. and Chen, P., 2020. Overexpression of microRNA-133a inhibits apoptosis and autophagy in a cell model of Parkinson’s disease by downregulating Ras-related C3 botulinum toxin substrate 1 (RAC1). Medical Science Monitor 26: e922032. 10.12659/MSM.922032
Lv, Z., Hu, M., Zhen, J., Lin, J., Wang, Q. and Wang, R., 2013. Rac1/PAK1 signaling promotes epithelial-mesenchymal transition of podocytes in vitro via triggering beta-catenin transcriptional activity under high glucose conditions. International Journal of Biochemistry & Cell Biology 45: 255–264. 10.1016/j.biocel.2012.11.003
Moghiman, T., Barghchi, B., Esmaeili, S.A., Shabestari, M.M., Tabaee, S.S. and Momtazi-Borojeni, A.A., 2021. Therapeutic angiogenesis with exosomal microRNAs: an effectual approach for the treatment of myocardial ischemia. Heart Failure Reviews 26: 205–213. 10.1007/s10741-020-10001-9
Navickas, R., Gal, D., Laucevicius, A., Taparauskaite, A., Zdanyte, M. and Holvoet, P., 2016. Identifying circulating microRNAs as biomarkers of cardiovascular disease: a systematic review. Cardiovascular Research 111: 322–337. 10.1093/cvr/cvw174
Oakes, S.A. and Papa, F.R., 2015. The role of endoplasmic reticulum stress in human pathology. Annual Review of Pathology 10: 173–194. 10.1146/annurev-pathol-012513-104649
Ong, H.K., Soo, B.P.C., Chu, K.L. and Chao, S.H., 2018. XBP-1, a cellular target for the development of novel anti-viral strategies. Current Protein & Peptide Science 19: 145–154. 10.2174/1389203718666170911144812
Oyadomari, S. and Mori, M., 2004. Roles of CHOP/GADD153 in endoplasmic reticulum stress. Cell Death and Differentiation 11: 381–389. 10.1038/sj.cdd.4401373
Payapilly, A. and Malliri, A., 2018. Compartmentalisation of RAC1 signalling. Current Opinion in Cell Biology (COCEBI) 54: 50–56. 10.1016/j.ceb.2018.04.009
Platania, C.B.M., Pittala, V., Pascale, A., Marchesi, N., Anfuso, C.D., Lupo, G., Cristaldi, M., Olivieri, M., Lazzara, F., Di Paola, L., Drago, F. and Bucolo, C., 2020. Novel indole derivatives targeting HuR-mRNA complex to counteract high glucose damage in retinal endothelial cells. Biochemical Pharmacology 175: 113908. 10.1016/j.bcp.2020.113908
Ravindran, S., Gao, Q., Ramachandran, A., Sundivakkam, P., Tiruppathi, C. and George, A., 2012. Expression and distribution of Grp-78/Bip in mineralizing tissues and mesenchymal cells. Histochemistry and Cell Biology 138: 113–125. 10.1007/s00418-012-0952-1
Song, T., Yao, Y., Wang, T., Huang, H. and Xia, H., 2017. Tanshinone IIA ameliorates apoptosis of myocardiocytes by up-regulation of miR-133 and suppression of caspase-9. European Journal of Pharmacology 815: 343–350. 10.1016/j.ejphar.2017.08.041
Soufi-Zomorrod, M., Hajifathali, A., Kouhkan, F., Mehdizadeh, M., Rad, S.M. and Soleimani, M., 2016. MicroRNAs modulating angiogenesis: miR-129-1 and miR-133 act as angio-miR in HUVECs. Tumour Biology 37: 9527–9534. 10.1007/s13277-016-4845-0
Taylor, R.C. and Dillin, A., 2013. XBP-1 is a cell-nonautonomous regulator of stress resistance and longevity. Cell 153: 1435–1447. 10.1016/j.cell.2013.05.042
Vecchione, C., Aretini, A., Marino, G., Bettarini, U., Poulet, R., Maffei, A., Sbroggio, M., Pastore, L., Gentile, M.T., Notte, A., Iorio, L., Hirsch, E., Tarone, G. and Lembo, G., 2006. Selective Rac-1 inhibition protects from diabetes-induced vascular injury. Circulation Research 98: 218–225. 10.1161/01.RES.0000200440.18768.30
Wang, J., Hu, R., Yin, C. and Xiao, Y., 2020. Tanshinone IIA reduces palmitate-induced apoptosis via inhibition of endoplasmic reticulum stress in HepG2 liver cells. Fundamental & Clinical Pharmacology 34: 249–262. 10.1111/fcp.12510
Wang, W., Guan, C., Sun, X., Zhao, Z., Li, J., Fu, X., Qiu, Y., Huang, M., Jin, J. and Huang, Z., 2016. Tanshinone IIA protects against acetaminophen-induced hepatotoxicity via activating the Nrf2 pathway. Phytomedicine 23: 589–596. 10.1016/j.phymed.2016.02.022
Xie, Z., Zhou, Y., Duan, X. and Yang, L., 2019. Inhibitory effect of tanshinone IIA on inverted formin-2 protects HaCaT cells against oxidative injury via regulating mitochondrial stress. Journal of Receptors and Signal Transduction 39: 134–145. 10.1080/10799893.2019.1638402
Xu, S., He, L., Ding, K., Zhang, L., Xu, X., Wang, S. and Qian, X., 2020a. Tanshinone IIA ameliorates streptozotocin-induced diabetic nephropathy, partly by attenuating PERK pathway-induced fibrosis. Drug Design, Development and Therapy 14: 5773–5782. 10.2147/DDDT.S257734
Xu, H., Li, H., Zhu, P., Liu, Y., Zhou, M. and Chen, A., 2020b. Tanshinone IIA ameliorates progression of CAD through regulating cardiac H9c2 cells proliferation and apoptosis by miR-133a-3p/EGFR axis. Drug Design, Development and Therapy 14: 2853–2863. 10.2147/DDDT.S245970
Yasuda, H., Iwata, Y., Nakajima, S., Furuichi, K., Miyake, T., Sakai, N., Kitajima, S., Toyama, T., Shinozaki, Y., Sagara, A., Miyagawa, T., Hara, A., Shimizu, M., Kamikawa, Y., Sato, K., Oshima, M., Yoneda-Nakagawa, S., Kaneko, S. and Wada, T., 2019. Erythropoietin signal protected human umbilical vein endothelial cells from high glucose-induced injury. Nephrology (Carlton) 24: 767–774. 10.1111/nep.13518
Yuan, J.-B., Gu, L., Chen, L., Yin, Y. and Fan, B.-Y., 2021. Annexin A8 regulated by lncRNA-TUG1/miR-140-3p axis promotes bladder cancer progression and metastasis. Molecular Therapy-Oncolytics 22: 36-51. 10.1016/j.omto.2021.04.008
Zhang, L., Wu, Y., Li, Y., Xu, C., Li, X., Zhu, D., Zhang, Y., Xing, S., Wang, H., Zhang, Z. and Shan, H., 2012. Tanshinone IIA improves miR-133 expression through MAPK ERK1/2 pathway in hypoxic cardiac myocytes. Cellular Physiology and Biochemistry 30: 843–852. 10.1159/000341462
Zhang, H., Wu, S., Yang, Y., Su, R., Wen, J., Ke, X. and Chen, W., 2018. Crocin protects human umbilical vein endothelial cells from high glucose-induced injury via inhibiting the endoplasmic reticulum stress response. Current Molecular Medicine 18: 166–177. 10.2174/1566524018666180727094658
Zhang, S., Zhao, X., Hao, J., Zhu, Y., Wang, Y., Wang, L., Guo, S., Yi, H., Liu, Y. and Liu, J., 2021. The role of ATF6 in Cr(VI)-induced apoptosis in DF-1 cells. Journal of Hazardous Materials 410: 124607. 10.1016/j.jhazmat.2020.124607
Zhao, M., Wang, S., Zuo, A., Zhang, J., Wen, W., Jiang, W., Chen, H., Liang, D., Sun, J. and Wang, M., 2021. HIF-1alpha/JMJD1A signaling regulates inflammation and oxidative stress following hyperglycemia and hypoxia-induced vascular cell injury. Cellular & Molecular Biology Letters 26: 40. 10.1186/s11658-021-00283-8
Zhou, B., Li, L.H., Tan, L.M., Luo, W.B., Xiong, H., Lu, X.L., Liu, D., Li, W.Y., Guo, Y.X., Tang, Z. and Zhu, L.G., 2021. Tanshinone IIA ameliorates inflammation response in osteoarthritis via inhibition of miR-155/FOXO3 axis. Pharmacology 106: 20–28. 10.1159/000505493
Zhou, L., Sui, H., Wang, T., Jia, R., Zhang, Z., Fu, J., Feng, Y., Liu, N., Ji, Q., Wang, Y., Zhang, B., Li, Q. and Li, Y., 2020. Tanshinone IIA reduces secretion of proangiogenic factors and inhibits angiogenesis in human colorectal cancer. Oncology Reports 43: 1159–1168. 10.3892/or.2020.7498